1. Home
  2. IMRX vs NMI Comparison

IMRX vs NMI Comparison

Compare IMRX & NMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • NMI
  • Stock Information
  • Founded
  • IMRX 2008
  • NMI 1988
  • Country
  • IMRX United States
  • NMI United States
  • Employees
  • IMRX N/A
  • NMI N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • NMI Trusts Except Educational Religious and Charitable
  • Sector
  • IMRX Health Care
  • NMI Finance
  • Exchange
  • IMRX Nasdaq
  • NMI Nasdaq
  • Market Cap
  • IMRX 117.0M
  • NMI 97.0M
  • IPO Year
  • IMRX 2021
  • NMI N/A
  • Fundamental
  • Price
  • IMRX $5.60
  • NMI $9.69
  • Analyst Decision
  • IMRX Strong Buy
  • NMI
  • Analyst Count
  • IMRX 4
  • NMI 0
  • Target Price
  • IMRX $13.00
  • NMI N/A
  • AVG Volume (30 Days)
  • IMRX 856.7K
  • NMI 28.4K
  • Earning Date
  • IMRX 08-13-2025
  • NMI 01-01-0001
  • Dividend Yield
  • IMRX N/A
  • NMI 4.10%
  • EPS Growth
  • IMRX N/A
  • NMI N/A
  • EPS
  • IMRX N/A
  • NMI N/A
  • Revenue
  • IMRX N/A
  • NMI N/A
  • Revenue This Year
  • IMRX N/A
  • NMI N/A
  • Revenue Next Year
  • IMRX N/A
  • NMI N/A
  • P/E Ratio
  • IMRX N/A
  • NMI N/A
  • Revenue Growth
  • IMRX N/A
  • NMI N/A
  • 52 Week Low
  • IMRX $1.10
  • NMI $8.30
  • 52 Week High
  • IMRX $6.18
  • NMI $10.05
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 64.27
  • NMI 42.34
  • Support Level
  • IMRX $3.25
  • NMI $9.66
  • Resistance Level
  • IMRX $6.18
  • NMI $9.82
  • Average True Range (ATR)
  • IMRX 0.52
  • NMI 0.09
  • MACD
  • IMRX 0.21
  • NMI -0.00
  • Stochastic Oscillator
  • IMRX 70.88
  • NMI 23.08

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About NMI Nuveen Municipal Income Fund Inc.

Nuveen Municipal Income Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.

Share on Social Networks: